Scientists at the Lausanne University Hospital and the Ludwig Institute for Cancer Research have reported a striking proof of concept: a personalized neoantigen vaccine given to a patient with ...
From the Dr. Frederick “Erick” Matsen and Dr. Philip Bradley labs, Biostatistics and Computational Biology Program, Cancer Consortium. “Broadly, our work raises questions about how the TCR generation ...
Expression of proliferation markers POLG and EIF2AK3 positively correlate with TCR CDR3-DDX53 Combo CSs. “In this ESCA study, the possibility of an immune response that selected for tumor cells ...
A new research paper has been published in Oncoscience, titled "An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen." T-lymphocytes have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results